Skip to main content
WGS
NASDAQ Life Sciences

GeneDx Q3 Revenue Up 5% but Adjusted Profit Halves; Guidance Trimmed

Tom Rudovsky · Reported by BusinessWire
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$65.65
Mkt Cap
$1.96B
52W Low
$32.21
52W High
$170.87
52W Position info
104% above low
Off High info
62% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

WGS has more than doubled off its 52-week low of $32.21 on elevated volume (2.1× avg).

Summary

Revenue rose 5% to $123.1M, but adjusted net income fell to $8.6M from $16.1M a year ago and GAAP net loss widened to $12.3M from $7.6M. Exome and genome volume grew 25% to 32,134 tests, yet adjusted gross margin slipped to 72% from 74%, so the volume growth is not converting into profit at last year's rate. Management trimmed full-year exome and genome revenue growth guidance to at least 17% from at least 20% and now expects roughly $12M of adjusted net income for the year, with Q4 revenue guided to $135M. The balance sheet shows $171.1M of cash and marketable securities against $146.2M of long-term debt, and the nine-month cash flow statement shows $72.0M used in operations. This is the first hard look at the post-Fabric Genomics cost structure after the $31.3M impairment and debt refinancing earlier this year.

At the time of this announcement, WGS was trading at $65.65 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2B. The 52-week trading range was $32.21 to $170.87. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

WGS - Latest Insights

WGS
Nov 10, 2026, 7:08 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $58.00
Real-time Price: $54.83 info
Change: -$3.17 (-5%) info
Market Cap: $1.635B info
WGS
Nov 09, 2026, 4:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $59.00
Real-time Price: $54.83 info
Change: -$4.17 (-7%) info
Market Cap: $1.635B info
WGS
Aug 03, 2026, 4:19 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.01
Real-time Price: $54.83 info
Change: -$22.18 (-29%) info
Market Cap: $1.635B info
WGS
Aug 03, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.47
Real-time Price: $54.83 info
Change: -$7.64 (-12%) info
Market Cap: $1.635B info
WGS
Aug 03, 2026, 4:12 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $60.19
Real-time Price: $54.83 info
Change: -$5.36 (-9%) info
Market Cap: $1.635B info